G6PD and malaria: According to the current treatment guidelines in Myanmar, uncomplicated P. vivax malaria is treated with chloroquine (CQ) and a 14-day course of primaquine (PQ) at a dosage of 0.25 mg/kg/day, without glucose-6-phosphate dehydrogenase (G6PD) testing, and is administered by basic healthcare staff in public health facilities and trained malaria volunteers in community settings.3